Eywa Pharma Private Limited - Company Profile

Q: Where is Eywa Pharma Private Limited headquartered?

Eywa Pharma Private Limited is headquartered at Door No.5A5, Third Cross Road,Sipcot It Park,, Siruseri, Chinglepet, Tamil Nadu, 603103.

It is a pharma private limited company based in Chinglepet, Tamil Nadu, India, established in 2015.

2015 Chinglepet, Tamil Nadu, India Active

Last Updated: February 10, 2026

Access Report

About Eywa Pharma Private Limited

Eywa Pharma Private Limited, a active private limited company, was established on 27 April 2015 in Chinglepet, Tamil Nadu, India. Engaging in drug formulation & development within the professional, scientific and technical sector, it holds CIN: U74900TN2015PTC100269. Registered under ROC Roc Chennai. it is unlisted. It has an authorized capital of ₹30.00 Cr and a paid-up capital of ₹29.29 Cr.

It upholds a compliant status. Employing 24 professional, Its leadership includes Sivakumar Jayaraman (Whole-Time Director), Seshan Srinivasan (Director). Past directors included Ravi Devaki Venkataraman, Srinivasan Ramani Harikesanallur, Subrata Ghosh. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at Door No.5/A5, Third Cross Road,Sipcot It Park,, Siruseri, Chinglepet, Tamil Nadu, 603103.

Company Details

CIN/LLPIN
U74900TN2015PTC100269
Registration Number
100269
Incorporation Date
27 April 2015
Authorized Capital
₹30.00 Cr
Paid-Up Capital
₹29.29 Cr
ROC Code
Roc Chennai
Listing Status
Unlisted
Company Status
Active

Key Metrics

Authorised Capital ₹ 30.00 Cr as on 10-02-2026
Paid Up Capital ₹ 29.29 Cr as on 10-02-2026
Company Age 10 Year, 9 Months
Last Filing with ROC 31 Mar 2025
Revenue Growth **** -21.66% (FY 2023)
Profit Growth **** -3601.26% (FY 2023)
Ebitda **** -580.27% (FY 2023)
Net Worth -9.62% (FY 2023)
Total Assets **** 14.52% (FY 2023)

Comprehensive Company Insights

Explore comprehensive insights into Eywa Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report

Who are the key members and board of directors at Eywa Pharma Private Limited?

Current Directors

Name	Designation	Appointment Date	Status
Sivakumar Jayaraman	Whole-Time Director	28 Jul 2018	Current
Seshan Srinivasan	Director	30 Apr 2025	Current

Past Directors

Name	Designation	Cessation	Status
Pramod Abcsdd	Director	22 Feb 2017	Past
Pramod Abcsdd	Director	22 Feb 2017	Past
Pramod Abcsdd	Whole-Time Director	29 Feb 2024	Past
Pramod Abcsdd	Managing Director	30 Apr 2025	Past
Pramod Abcsdd	Director	28 Jul 2018	Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Eywa Pharma.

Eywa Pharma Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 21.66% decrease. The company also saw a substantial fall in profitability, with a 3601.26% decrease in profit. The company's net worth dipped by a decrease of 9.62%.

Date	Amount	Transaction Name	Valuation	Lead Investors	Investors
Jul, 2021	Amount	Post-IPO - Grab	Valuation	investors	Emtek
Feb, 2021	Amount	Post-IPO - Grab	Valuation	investors	Signite Partners
Jan, 2021	Amount	Post-IPO - Grab	Valuation	investors	Hana Financial Group , GGV Capital
Feb, 2021	Amount	Post-IPO - Grab	Valuation	investors	Signite Partners

Upgrade Required

Full access to Financial is available only for users with an active Premium plan.

Key Matrics
Balance Sheet
Profit and Loss
Cash Flow
Ratios

Metrics

(FY 2023)

YOY Growth

(FY 2022)

(FY 2021)

(FY 2020)

(FY 2019)

Total Revenue

********

-21.66%

*******

Revenue from Operations

*******

-38.45%

*******

Total Assets

*******

14.52%

*******

Profit or Loss

*******

-3601.26%

*******

Net Worth

*******

-9.62%

*******

EBITDA

*******

-580.27%

*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Eywa Pharma?

In 2023, Eywa Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)

Promoters: 92.83%
Public: 4.10%
Others: 3.07%

Shareholding Pattern over the Year

	FY (2024)	FY (2023)	FY (2022)	FY (2021)	FY (2020)
Promoters	92.83	94.62	94.55	94.55	94.55
Public	4.10	3.89	3.95	3.96	3.98
Others	3.07	1.49	1.50	1.49	1.47

Upgrade Required

Full access to Ownership and Shareholding Structure is available only for users with an active Premium plan.

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Eywa Pharma?

Eywa Pharma has a workforce of 24 employees as of Apr 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date	Number of Employees
2020	78,000
2021	80,500
2022	83,200
2023	86,000
2024	89,500
2025	92,000

Upgrade Required

Full access to People is available only for users with an active Premium plan.

Deals i

Gain comprehensive insights into the Deals and Valuation data of Eywa Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Eywa Pharma's trajectory.

Rating

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Eywa Pharma

Recent Activity within the Organization

Annual General Meeting

Eywa Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was recorded as a recent event.
30 Sep 2025
Director Appointment

Seshan Srinivasan was appointed as a Director was appointed as a Director on 30 Apr 2025 & has been associated with this company since 9 months 16 days . was recorded as a recent event.
30 Apr 2025
Balance Sheet

Progress on Eywa Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Chennai. was documented.
31 Mar 2025
Director Appointment

Sivakumar Jayaraman was appointed as a Whole-time director was appointed as a Whole-time director on 28 Jul 2018 & has been associated with this company since 7 years 6 months . was recorded as a recent event.
28 Jul 2018
Director Appointment

Sivakumar Jayaraman was appointed as a Company Secretary was appointed as a Company Secretary on 11 Aug 2016 & has been associated with this company since 9 years 6 months . was recorded as a recent event.
11 Aug 2016
Company Incorporation

Progress on Eywa Pharma Private Limited was registered on 27 Apr 2015 with Roc Chennai & aged 10 years 9 months as per MCA records. was documented.
27 Apr 2015

Explore recent activity and updates - View Recent Activity